Sept. 20 (Bloomberg) -- A research team including the University of Tokyo and Chugai Pharmaceutical Corp. has started developing a cancer treatment using antibodies and radiation, the Nikkei newspaper reported.
The members also including Fujifilm Holdings Corp. and Osaka University aim to develop treatments that reduce side effects to cure cancers of the colon, lungs, liver and pancreas, the newspaper reported without saying where it obtained the information. The group hopes to complete tests on animals within three years.
The drug will be designed by the University of Tokyo and Osaka University, and production will be handled by Chugai, the Nikkei said. Fujifilm will develop substances for radiation treatment, according to the report.
To contact the reporter on this story: Masumi Suga in Tokyo at email@example.com;
To contact the editor responsible for this story: Jonathan Annells at firstname.lastname@example.org